SANA FY 2024 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$273M

Net Income

-$267M

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$223M

Free Cash Flow

-$257M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$501M

Total Liabilities

$251M

Stockholders' Equity

$251M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$273M	-$293M	+7.0%
Net Income	-$267M	-$283M	+5.8%